IGC Pharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2011 | $-2.6M | $-2.9M | $285.4K | — |
| FY2012 | $-5.0M | $-5.0M | $5.5K | $-23.3K |
| FY2013 | $564.8K | $238.8K | $326.1K | $824.8K |
| FY2014 | $-1.7M | $-1.8M | $8.5K | $181.0K |
| FY2015 | $-2.6M | $-2.7M | $76.5K | $833.1K |
| FY2016 | $-157.7K | $-279.9K | $122.2K | $214.3K |
| FY2017 | $-1.4M | $-1.5M | $145.7K | $250.6K |
| FY2018 | $-1.9M | $-2.1M | $136.0K | $576.3K |
| FY2019 | $-3.3M | $-3.3M | $15.0K | $515.0K |
| FY2020 | $-8.7M | $-13.1M | $4.4M | $521.0K |
| FY2021 | $-10.8M | $-12.3M | $1.5M | $703.0K |
| FY2022 | $-7.5M | $-7.7M | $236.0K | $7.0M |
| FY2023 | $-7.0M | $-7.4M | $310.0K | $5.5M |
| FY2024 | $-5.2M | $-5.3M | $138.0K | $4.6M |
| FY2025 | $-4.8M | $-4.9M | $112.0K | $4.3M |